Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Tumor-immune microenvironment and NRF2 associate with clinical efficacy of PD-1 blockade combined with chemotherapy in lung squamous cell carcinoma

Class:IdLiteratureReference:9912058
_displayNameTumor-immune microenvironment and NRF2 associate with clinical efficacy of PD-1 blockade combined with chemotherapy in lung squamous cell carcinoma
_timestamp2024-06-06 16:51:52
author[Person:9912126] Duan, Jianchun
[Person:5227012] Zhang, Yun
[Person:9912141] Chen, Ran
[Person:8871047] Liang, Liang
[Person:9912041] Huo, Yi
[Person:9713959] Lu, Shun
[Person:8862458] Zhao, Jun
[Person:9912039] Hu, Chunhong
[Person:9828792] Sun, Yuping
[Person:9912036] Yang, Kunyu
[Person:9912075] Chen, Mingwei
[Person:9912060] Yu, Yan
[Person:9713339] Ying, Jianming
[Person:9912051] Huang, Ruiqi
[Person:9912130] Ma, Xiaopeng
[Person:9912050] Leaw, Shiangjiin
[Person:9715971] Bai, Fan
[Person:8851611] Shen, Zhirong
[Person:9912124] Cai, Shangli
[Person:8873956] Gao, Daming
[Person:3782543] Wang, Jie
[Person:9912040] Wang, Zhijie
created[InstanceEdit:9912117] Tiwari, Krishna, 2024-06-06
journalCell Rep Med
pages101302
pubMedIdentifier38052215
titleTumor-immune microenvironment and NRF2 associate with clinical efficacy of PD-1 blockade combined with chemotherapy in lung squamous cell carcinoma
volume4
year2023
(literatureReference)[Summation:9912049] NFE2L2 (NRF2/(Nuclear Factor Erythroid 2–Related Factor 2) ...
[Reaction:9909652] NFE2L2 binding to CD274 gene [Homo sapiens]
[RegulationReference:9912806] Positive gene expression regulation by 'NRF2:CD274 gene [nucleoplasm]' Tumor-immune microenvironment and NRF2 associate with clinical efficacy of PD-1 blockade combined with chemotherapy in lung squamous cell carcinoma
[Change default viewing format]
No pathways have been reviewed or authored by Tumor-immune microenvironment and NRF2 associate with clinical efficacy of PD-1 blockade combined with chemotherapy in lung squamous cell carcinoma (9912058)